Stockreport

Macrogenics Inc (MGNX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Developments [Yahoo! Finance]

Incyte Corporation  (INCY) 
Last incyte corporation earnings: 2/13 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: incyte.com/ir/investor-overview.aspx
PDF Research and Development Expenses: $40.5 million for Q3 2024, up from $30.1 million in Q3 2023. Selling, General and Administrative Expenses: $14.1 million for Q3 202 [Read more]